Rare Olive Org Inc supports treatment research and patient advocacy for Lunapark Syndrome LNPK an ultra-rare genetic disorder. Founded by a family whose daughter was the first known LNPK case in the United States we are committed to building a path forward for patients and families worldwide.
Main program · fiscal year 2024
Sponsored research grant with the Gray Lab at University of Texas Southwestern to develop validate and test safety efficacy of a gene therapy replacement therapy in restoring the LNPK protein in a mouse disease model.
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$414,642Fiscal year 2024
Expenses$303,287Fiscal year 2024
Total assets$137,497Fiscal year 2024
Total liabilities$0Fiscal year 2024
Fiscal year ending December2024
Revenue$414,642
Expenses$303,287
Net income$111,355
Net assets$137,497
Notable sources of revenue
Percent of total revenue
Contributions
$404,398
97.5%
Program services
$0
0.0%
Investment income
$915
0.2%
Other (net)
$9,329
2.2%
Assets / debt
Total assets
$137,497
Total liabilities
$0
Net assets
$137,497
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$76,978
Expenses$103,054
Net income−$26,076
Net assets$26,130
Notable sources of revenue
Percent of total revenue
Contributions
$61,307
79.6%
Program services
—
—
Investment income
$98
0.1%
Other (net)
$15,573
20.2%
Assets / debt
Total assets
—
Total liabilities
—
Net assets
$26,130
Compensation
Not in our extract for this year.
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?